Search research articles
Contact Us
Filters
Showing results (21-30 of 46) with videos related to
Page
of 5
Sort By:
International Journal of Molecular Sciences
|
October 27, 2022
Developing Bi-Gold Compound BGC2a to Target Mitochondria for the Elimination of Cancer Cells
Qingbin Cui, Wenwen Ding, Panpan Liu, et al.
Oncology Reports
|
May 7, 2019
The targeting of non‑coding RNAs by curcumin: Facts and hopes for cancer therapy (Review)
Yun Liu, Hongmei Sun, Bolat Makabel, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy
|
January 15, 2026
Novel quinoxaline-based survivin degraders overcome docetaxel-resistance in castration-resistant prostate cancer
Caoqinglong Huang, Xunzhen Zheng, Qingbin Cui, et al.
Frontiers in Pharmacology
|
July 31, 2023
The AKT inhibitor, MK-2206, attenuates ABCG2-mediated drug resistance in lung and colon cancer cells
Hai-Ling Gao, Qingbin Cui, Jing-Quan Wang, et al.
Medcomm
|
November 12, 2021
Insights on the structure-function relationship of human multidrug resistance protein 7 (MRP7/ABCC10) from molecular dynamics simulations and docking studies
Jing-Quan Wang, Qingbin Cui, Zi-Ning Lei, et al.
Bioorganic & Medicinal Chemistry
|
May 3, 2022
A novel survivin dimerization inhibitor without a labile hydrazone linker induces spontaneous apoptosis and synergizes with docetaxel in prostate cancer cells
Robert Peery, Qingbin Cui, Kwaku Kyei-Baffour, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy
|
January 29, 2021
Multidrug resistance proteins (MRPs): Structure, function and the overcoming of cancer multidrug resistance
Jing-Quan Wang, Yuqi Yang, Chao-Yun Cai, et al.
Bioorganic & Medicinal Chemistry
|
December 14, 2022
Corrigendum to "A novel survivin dimerization inhibitor without a labile hydrazone linker induces spontaneous apoptosis and synergizes with docetaxel in prostate cancer cells" [Bioorg. Med. Chem. 65 (2022) 116761]
Robert Peery, Qingbin Cui, Kwaku Kyei-Baffour, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy
|
November 25, 2018
Modulating ROS to overcome multidrug resistance in cancer
Qingbin Cui, Jing-Quan Wang, Yehuda G Assaraf, et al.
International Journal of Molecular Sciences
|
August 25, 2019
Chk1 Inhibitor MK-8776 Restores the Sensitivity of Chemotherapeutics in P-glycoprotein Overexpressing Cancer Cells
Qingbin Cui, Chao-Yun Cai, Jing-Quan Wang, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 46) with videos related to
Sort By:
Page
of 5
International Journal of Molecular Sciences
|
October 27, 2022
Developing Bi-Gold Compound BGC2a to Target Mitochondria for the Elimination of Cancer Cells
Qingbin Cui, Wenwen Ding, Panpan Liu, et al.
Oncology Reports
|
May 7, 2019
The targeting of non‑coding RNAs by curcumin: Facts and hopes for cancer therapy (Review)
Yun Liu, Hongmei Sun, Bolat Makabel, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy
|
January 15, 2026
Novel quinoxaline-based survivin degraders overcome docetaxel-resistance in castration-resistant prostate cancer
Caoqinglong Huang, Xunzhen Zheng, Qingbin Cui, et al.
Frontiers in Pharmacology
|
July 31, 2023
The AKT inhibitor, MK-2206, attenuates ABCG2-mediated drug resistance in lung and colon cancer cells
Hai-Ling Gao, Qingbin Cui, Jing-Quan Wang, et al.
Medcomm
|
November 12, 2021
Insights on the structure-function relationship of human multidrug resistance protein 7 (MRP7/ABCC10) from molecular dynamics simulations and docking studies
Jing-Quan Wang, Qingbin Cui, Zi-Ning Lei, et al.
Bioorganic & Medicinal Chemistry
|
May 3, 2022
A novel survivin dimerization inhibitor without a labile hydrazone linker induces spontaneous apoptosis and synergizes with docetaxel in prostate cancer cells
Robert Peery, Qingbin Cui, Kwaku Kyei-Baffour, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy
|
January 29, 2021
Multidrug resistance proteins (MRPs): Structure, function and the overcoming of cancer multidrug resistance
Jing-Quan Wang, Yuqi Yang, Chao-Yun Cai, et al.
Bioorganic & Medicinal Chemistry
|
December 14, 2022
Corrigendum to "A novel survivin dimerization inhibitor without a labile hydrazone linker induces spontaneous apoptosis and synergizes with docetaxel in prostate cancer cells" [Bioorg. Med. Chem. 65 (2022) 116761]
Robert Peery, Qingbin Cui, Kwaku Kyei-Baffour, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy
|
November 25, 2018
Modulating ROS to overcome multidrug resistance in cancer
Qingbin Cui, Jing-Quan Wang, Yehuda G Assaraf, et al.
International Journal of Molecular Sciences
|
August 25, 2019
Chk1 Inhibitor MK-8776 Restores the Sensitivity of Chemotherapeutics in P-glycoprotein Overexpressing Cancer Cells
Qingbin Cui, Chao-Yun Cai, Jing-Quan Wang, et al.
Page
of 5